APA (7th ed.) Citation

E, C., MR, L., H, A., I, A., PW, B., RD, C., . . . D, D. (2025). Recognition, prevention, and management of adverse events associated with asparaginase/ pegaspargase treatment of acute lymphoblastic leukemia in adults: Consensus of an expert panel. Haematologica, 110(12), 2913. https://doi.org/10.3324/haematol.2024.286744

Chicago Style (17th ed.) Citation

E, Curran, et al. "Recognition, Prevention, and Management of Adverse Events Associated with Asparaginase/ Pegaspargase Treatment of Acute Lymphoblastic Leukemia in Adults: Consensus of an Expert Panel." Haematologica 110, no. 12 (2025): 2913. https://doi.org/10.3324/haematol.2024.286744.

MLA (9th ed.) Citation

E, Curran, et al. "Recognition, Prevention, and Management of Adverse Events Associated with Asparaginase/ Pegaspargase Treatment of Acute Lymphoblastic Leukemia in Adults: Consensus of an Expert Panel." Haematologica, vol. 110, no. 12, 2025, p. 2913, https://doi.org/10.3324/haematol.2024.286744.